#Japan #Medical Device #Healthcare Imaging #Koganei #ASEMtech

ASEMtech's New Horizon in Medical Technology

ASEMtech Corporation, headquartered in Koganei City, Tokyo, proudly announces its recent achievement of obtaining a second-class medical device manufacturing and sales license from the Tokyo Metropolitan Government, effective July 8, 2025. This significant milestone enables ASEMtech to manufacture and distribute Class II medical devices, broadening its scope within the healthcare market and positively impacting patient care.

Understanding the ASEM Methodology

At the heart of ASEMtech's offerings lies the ASEM method, a sophisticated technology harnessing ultrasound to convert electrical signals generated within bodily tissues into high-resolution images. This method leverages the piezoelectric effect of biological tissues to assess the orientation and accumulation of collagen fibers. ASEMtech's ultimate aim is to provide healthcare professionals with crucial information regarding various ailments associated with fibrous tissue, as well as musculoskeletal disorders, including tendinopathies, ligament injuries, and conditions like chronic kidney disease and myocardial infarction that arise from changes in collagen fiber orientation or excessive accumulation.

Collagen, a vital protein that forms the framework of our bodies, is ubiquitous in musculoskeletal structures, blood vessels, and organs. With the global population aging, accurately diagnosing and treating musculoskeletal disorders, such as fractures and joint diseases, is increasingly vital, as these conditions contribute significantly to disabilities requiring care assistance. The ability to maintain mobility is crucial for independent living and enhances quality of life (QOL), while also holding substantial economic value, particularly for the working-age population aiming for swift recovery from injuries like fractures and tendon ruptures.

Innovating in Imaging Diagnostics

In response to these pressing needs, ASEMtech is developing cutting-edge imaging diagnostic devices utilizing the ASEM technique. The company aims to tackle challenges in diagnosing fibrotic diseases and musculoskeletal disorders, evaluating treatment effectiveness, and facilitating assessments in rehabilitation settings. By providing better diagnostic tools, ASEMtech hopes to revolutionize the way medical practitioners approach these health issues, ultimately improving patient outcomes.

Company Overview

ASEMtech Corporation was established in November 2023 and operates from its headquarters located at 2-24-16 Nakacho, Koganei City, Tokyo, in the Advanced Industry-Academic Collaboration Research Promotion Center (URAC) room 106 of Tokyo University of Agriculture and Technology's Koganei campus. Led by CEO Kenji Ikushima and Vice President Nobuo Shinmi, ASEMtech is committed to advancing the research, development, design, manufacturing, sales, and rental of medical devices and non-destructive testing instruments related to the ASEM method.

For more information about ASEMtech’s innovative projects and products, please visit their official website at asem-tech.com.

By bridging the gaps in diagnosis and treatment of critical health issues, ASEMtech Corporation is poised to make a significant impact within the medical technology landscape, improving both clinical practices and patient experiences.